DarioHealth Corp. (DRIO)
0.70
0.01 (1.73%)
At close: Mar 24, 2025, 3:59 PM
0.72
1.92%
After-hours: Mar 24, 2025, 07:59 PM EDT
1.73% (1D)
| Bid | 0.71 |
| Market Cap | 29.27M |
| Revenue (ttm) | 27.79M |
| Net Income (ttm) | -33.14M |
| EPS (ttm) | -0.61 |
| PE Ratio (ttm) | -1.15 |
| Forward PE | -1.77 |
| Analyst | Buy |
| Ask | 0.72 |
| Volume | 443,805 |
| Avg. Volume (20D) | 769,510 |
| Open | 0.69 |
| Previous Close | 0.69 |
| Day's Range | 0.69 - 0.74 |
| 52-Week Range | 0.56 - 1.93 |
| Beta | 1.42 |
About DRIO
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chron...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Mar 14, 2016
Employees 196
Stock Exchange NASDAQ
Ticker Symbol DRIO
Website https://www.mydario.com
Analyst Forecast
According to 1 analyst ratings, the average rating for DRIO stock is "Buy." The 12-month stock price forecast is $2, which is an increase of 184.05% from the latest price.
Stock Forecasts1 month ago
+11.62%
DarioHealth shares are trading higher on possible ...
Unlock content with
Pro Subscription
2 months ago
+2.31%
DarioHealth shares are trading higher following the announcement of a $25.6 million private placement of convertible preferred stock.
